Home › Funds › James Hambro & Partners LLP › JNJ

James Hambro & Partners LLP position in JNJ

JOHNSON JOHNSON · Health Care

James Hambro & Partners LLP reported holding 2,534 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$671K, representing 0.02% of its reported portfolio and ranking #46 among its reported holdings. James Hambro & Partners LLP has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.53K sh
Reported value held$671.28K
Portfolio Weight0.02%
First reportedQ3 2023
Last changeAdd
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How James Hambro & Partners LLP's JNJ position evolved

James Hambro & Partners LLP first disclosed a stake in JNJ in Q3 2023 at 4,188 shares (US$652K). The position peaked in Q3 2026 at 2,534 shares, worth US$671K. Across 13 filings, James Hambro & Partners LLP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,534 shares valued at US$671K — an increase of 859 shares quarter over quarter.. Notable position changes include a 37% trim in Q4 2025 (shares rose 18% over the following quarter), a 51% increase in Q3 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.19K $652.47K New
Q4 2023 3.62K $567.75K Reduce
Q1 2024 4.09K $647.56K Add
Q2 2024 3.78K $552.02K Reduce
Q3 2024 3.64K $589.39K Reduce
Q4 2024 2.84K $410.47K Reduce
Q1 2025 2.84K $470.78K Hold
Q2 2025 2.46K $375.24K Reduce
Q3 2025 2.32K $429.75K Reduce
Q4 2025 1.47K $303.39K Reduce
Q1 2026 1.71K $417.69K Add
Q2 2026 1.68K $425.42K Reduce
Q3 2026 2.53K $671.28K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has James Hambro & Partners LLP held JNJ?

James Hambro & Partners LLP has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is James Hambro & Partners LLP's current position in JNJ?

As of Q3 2026, James Hambro & Partners LLP holds 2.53K shares of JNJ (JOHNSON JOHNSON), valued at $671.28K, representing 0.02% of its reported portfolio and ranking #46.

Has James Hambro & Partners LLP been buying or selling JNJ?

In the latest 13F filing (Q3 2026), James Hambro & Partners LLP increased its position in JNJ. The position peaked in Q3 2026 at 2.53K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.